MAPT and Alzheimer disease: Research indicates that changes in the gut microbial composition can result in changes in gut permeability, chronic systemic inflammation, and increased production of amyloid and tau proteins, which are hallmark features of AD, leading to neuroinflammation and neurodegeneration (Kowalski and Mulak, 2019).